Celularity, Inc. CELU
1.38
0.06
4.55%
as of 25 Sep
- Market cap
- $38.2M
- P/E
- 0.0×
Follow CELU
| Dec '25 | Sep '25 | Jun '25 | Mar '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.07 | 1.34 | 1.06 | 0.80 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(5.57) | (13.11) | (47.13) | (13.60) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.64 | 2.33 | 2.01 | 1.64 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.29) | (14.39) | (35.27) | (16.74) | |
EV/FCF |
(5.22) | (14.05) | (33.17) | (16.22) | |
Quick Ratio |
0.13 | 0.10 | 0.17 | 0.26 | |
Current Ratio |
0.15 | 0.16 | 0.25 | 0.38 | |
Net Debt/EBITDA |
(2.06) | (3.58) | (3.03) | (4.95) | |
Debt/Assets |
44.55% | 34.98% | 36.11% | 33.48% | |
Debt/Equity |
(1.26) | (1.99) | (1.70) | (7.84) | |
Asset Turnover |
0.22 | 0.33 | 0.35 | 0.37 | |
Operating CF/Net income |
0.21 | 0.18 | 0.04 | 0.15 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
81.55% | 87.02% | 58.44% | 32.63% | |
Selling, General and Administrative Expense of Revenue |
367.06% | 176.12% | 220.26% | 124.82% | |
Intangible Assets out of Total Assets |
0.14 | 0.14 | 0.13 | 0.13 | |
Share Based Compensation of Revenue |
79.24% | 38.63% | 42.68% | 23.08% | |
Graham Net Nets |
(4.68) | (2.27) | (2.73) | (2.76) | |
Graham Number |
10.95 | 7.56 | 8.71 | 3.60 | |
Earnings Yield |
(323.11%) | (160.87%) | (162.24%) | (142.20%) | |
Free Cash Flow Yield |
(47.21%) | (12.32%) | (5.74%) | (12.66%) | |
Revenue per Share |
0.16 | 0.20 | 0.24 | 0.49 | |
Operating CF per Share |
(0.20) | (0.16) | (0.04) | (0.13) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.20) | (0.16) | (0.04) | (0.13) | |
Cash per Share |
0.24 | 0.00 | 0.04 | 0.01 | |
Shareholders Equity per Share |
(1.49) | (0.76) | (1.06) | (0.23) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(1.49) | (0.76) | (1.06) | (0.23) | |
Free Cash Flow |
(5.10) | (4.16) | (1.00) | (2.99) | |
Working Capital |
(68.44) | (54.72) | (51.96) | (36.61) | |
Net Current Asset Value |
(133.07) | (123.74) | (128.52) | (112.30) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(595.66%) | (436.71%) | (427.55%) | (172.89%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
9.11 | 7.74 | 12.31 | 15.40 | |
Average Payables |
24.86 | 19.99 | 19.06 | 18.15 | |
Average Inventory |
2.99 | 3.26 | 3.66 | 4.95 | |
Average Assets |
120.01 | 121.54 | 127.89 | 136.35 | |
Average Common Equity |
(14.61) | (1.41) | 1.16 | 12.87 |
Columns are period end dates